Competition stiff for cephalosporin market

Published: 2010-08-19 07:00:00

Updated: 2010-08-19 07:00:00

Many major pharmaceutical manufacturers are rushing to produce cephalosporin antibiotics with hope of acquiring large share of the domestic cephalosporin market valued at 500 billion won, which is forecast to become more competitive than ever late this year.

The local market for cephalosporin ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK